Healthcare Trust, Inc. — Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2021. The supplied filing identifies the registrant as Healthcare Trust, Inc., not National Healthcare Properties, Inc.; investors should verify the issuer identity.
Business context and portfolio
Healthcare Trust is an externally managed U.S. REIT focused on medical office and other healthcare-related buildings (“MOBs”) and senior housing operating properties (“SHOPs”). In the fourth quarter of 2021, management consolidated the former triple-net healthcare segment into the MOB segment, resulting in two reportable segments: MOBs and SHOPs.
- Portfolio at year-end: 202 properties in 33 states, totaling 9.2 million rentable square feet.
- MOBs: 146 properties, 5.0 million square feet, 91.5% leased, with a 4.9-year weighted-average remaining lease term.
- SHOPs: 54 operating properties plus two land parcels, 4,494 rentable units, and 74.1% occupancy by unit count.
- Gross asset value: approximately $2.6 billion; Florida represented 17.7% of annualized rental income.
Financial performance and key metrics
| Metric | 2021 | 2020 | Change |
|---|---|---|---|
| Revenue from tenants | $329.4 million | $381.6 million | Down $52.3 million |
| Net loss | $85.4 million | $75.5 million | Loss increased $9.9 million |
| Net loss attributable to common stockholders | $92.9 million | $78.8 million | Loss increased $14.2 million |
| Net loss per common share | $0.92 loss | $0.79 loss | Loss increased |
| NOI | $123.5 million | $138.1 million | Down $14.5 million |
| FFO attributable to common stockholders | $21.9 million | $31.6 million | Down $9.6 million |
| MFFO attributable to common stockholders | $22.9 million | $34.3 million | Down $11.4 million |
| Cash flow from operations | $38.9 million | $41.8 million | Down $2.9 million |
Operating performance was divided by segment. MOB revenue increased to $122.9 million from $119.8 million and MOB NOI increased to $88.4 million from $87.0 million. SHOP revenue declined to $206.5 million from $261.8 million and SHOP NOI declined to $35.2 million from $51.1 million, primarily due to property dispositions, lower occupancy and reduced skilled-nursing activity.
Property operating and maintenance expenses were $205.8 million, compared with $243.5 million in 2020. The reduction was driven mainly by SHOP dispositions and $5.1 million of CARES Act grants recognized as a reduction of property operating expenses. The filing does not provide a consolidated GAAP operating margin; based on reported revenue and property operating expenses, consolidated property-level NOI margin was approximately 37.5% in 2021 versus 36.2% in 2020.
Liquidity, debt and capital structure
- Cash and cash equivalents: $59.7 million at December 31, 2021, down from $72.4 million.
- Total gross debt: approximately $1.1 billion; net debt: approximately $1.0 billion.
- Net debt to gross asset value: approximately 40.1%; consolidated total indebtedness to consolidated total asset value for covenant purposes: 59.4%.
- Weighted-average debt interest rate: 3.44%, compared with 3.58% in 2020.
- Mortgage notes payable: $591.8 million gross, including $42.8 million of new BMO financing.
- Credit facilities: $505.0 million gross, including $150.0 million under the term loan and $355.0 million under Fannie Mae facilities. No revolving credit borrowings were outstanding at year-end, with $236.6 million of stated availability.
- Scheduled principal maturities are concentrated in 2026, totaling approximately $545.6 million across mortgage notes and credit facilities.
- Nine interest-rate swaps had a notional amount of $578.5 million; nine interest-rate caps had a notional amount of approximately $355.2 million.
The company issued approximately $56.3 million of net Series A preferred stock proceeds and $86.9 million of net Series B preferred stock proceeds in 2021. Proceeds were primarily used to repay the revolving credit facility. Series A carries a 7.375% cumulative dividend and Series B carries a 7.125% cumulative dividend.
Material changes versus the prior comparable period
- Revenue declined 13.7%, while net loss attributable to common stockholders increased 18.0%.
- SHOP NOI decreased approximately 31.1%, reflecting COVID-19-related occupancy pressure and dispositions. SHOP occupancy was 74.1% at year-end, versus 74.5% at year-end 2020 and 85.1% at year-end 2019.
- MOB NOI increased modestly despite a $2.3 million decline in same-store NOI, primarily because acquisitions more than offset same-store and disposition impacts.
- Impairment charges increased to $41.0 million from $36.4 million. The 2021 charges included $34.0 million related to four LaSalle properties, $6.1 million for an MOB in Sun City, Arizona, and $0.9 million for Wellington.
- The company acquired 17 MOBs for an aggregate contract purchase price of $160.2 million and sold eight properties for an aggregate contract price of $133.6 million, producing a $3.6 million gain.
- Common-stock distributions remained entirely in shares during 2021; no cash common-stock dividends were paid. The company issued approximately 5.5 million shares through stock dividends.
- The share repurchase program remained suspended, and no common shares were repurchased in 2021.
Guidance, outlook, risks and unusual items
- Management expects SHOP occupancy and operating trends to improve in 2022 but cautions that COVID-19 variants, vaccination rates, move-in restrictions and labor costs could cause further deterioration.
- Management expects 2022 capital expenditures to be similar to 2021 levels, although the timing and amount remain subject to economic uncertainty. The filing does not provide formal earnings or revenue guidance.
- During 2021, MOB cash collections were approximately 100% of original contractual cash rent, and previously deferred rent was collected. This performance may not predict future collections.
- The company received $5.1 million of CARES Act grants in 2021, compared with $3.6 million in 2020. Future funding is uncertain, and noncompliance could require repayment.
- The company would have breached its fixed-charge coverage covenant for the period ended September 30, 2021 absent a lender waiver. The November 2021 amendment waived the breach and reduced the required ratio to 1.50:1.00 through the earlier of December 31, 2022 or termination of the relief period.
- The company satisfied conditions to designate the quarter ending March 31, 2022 as the “Commencement Quarter” for resuming cash common distributions but did not make the election. Cash common distributions remain subject to liquidity, leverage and other credit-facility conditions.
- There is no established public market for common stock. The last disclosed estimated per-share NAV was $14.50 as of December 31, 2020; an updated 2021 NAV was expected in early April 2022.
- Key risks include COVID-19, SHOP occupancy and labor costs, tenant and operator defaults, healthcare reimbursement and regulatory changes, inflation, interest-rate increases, concentrated Florida exposure, refinancing risk, environmental liabilities, dependence on external managers and conflicts with AR Global affiliates.
Important facts for investors to verify
- Confirm that this filing belongs to the requested company, because the filing names Healthcare Trust, Inc. rather than National Healthcare Properties, Inc.
- Review the full debt maturity schedule, particularly the approximately $545.6 million of 2026 scheduled maturities and the company’s refinancing options.
- Assess whether SHOP occupancy can recover from 74.1% toward pre-pandemic levels without materially higher labor and operating costs.
- Verify the updated December 31, 2021 estimated NAV and understand that it may not represent realizable value for common-stock holders.
- Monitor whether the company elects to resume cash common distributions and whether the applicable credit-facility conditions remain satisfied.
- Evaluate the sustainability of operating performance excluding $5.1 million of CARES Act support and other unusual items.
- Review the proposed sale of the four LaSalle properties for $12.4 million and the associated $34.0 million impairment for closing risk and further valuation consequences.
- Consider the effect of preferred-stock dividends, external-management fees and related-party reimbursements on cash available to common stockholders.